View Document Preview and Link
Open Document File Size: 91,05 KB Share Result on Facebook
Company Thomson / / Continent Europe / / Country United States / / / Event Product Recall / Product Issues / / Facility Medical University of Lodz / / IndustryTerm treatment of other allergic diseases / / MedicalCondition glaucoma / atopic dermatitis / JE / severe persistent asthma / arterial hypertension / hives / anaphylaxis / muscle weakness / good asthma / uncontrolled asthma / larynx angioedema / latex allergy / obesity / severe / uncontrolled asthma / allergic inflammation / uncontrolled allergic asthma / idiopathic anaphylaxis / eosinophilic gastroenteritis / hypersensitivity / inflammatory cells / severe persistent allergic asthma / seasonal and allergic rhinitis / chronic urticaria / infections / bronchopulmonary aspergillosis / chronic asthma / malignant neoplasms / Asthma / allergic diseases / spontaneous urticaria / bronchospasm / allergic asthma / disease / unchanged asthma / different diseases / reflux disease / diabetes / erythema / chronic rhinosinusitis / non-allergic asthma / severe allergic asthma / sleep apnea / urticaria / angioedema / osteoporosis / mastocytosis / uncontrolled chronic urticaria / peanut allergy / inflammation / symptomatic chronic idiopathic/spontaneous urticaria / severe asthma / cataract / chronic idiopathic urticaria / / MedicalTreatment pharmacotherapy / / Organization European Respiratory Society / Piotr Kuna Department of Internal Medicine / Asthma and Allergy / Department of Internal Medicine / Piotr Kuna Department of Internal Medicine / Congress / Medical University of Lodz / national health service / / Person Fernandez Vidaurre / Asthma / Ann Allergy / Piotr Kuna / Maciej Kupczyk / / / Position Walker / Head / controller / / Product follow-up / treatment / Xolair / / ProvinceOrState Maryland / South Carolina / / PublishedMedium the Cochrane review / / URL http / SocialTag